309A — Cosmos Chouzai Pharmacy Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro Cap

Annual income statement for Cosmos Chouzai Pharmacy, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Preliminary
Revenue
Total Revenue	5,804	6,187	6,293	6,511
Cost of Revenue
Gross Profit	2,558	2,744	2,822	2,916
Selling / General / Administrative Expenses
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	5,774	5,991	6,071	6,285
Operating Profit	30	196	222	226
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	140	204	245	244
Provision for Income Taxes
Net Income After Taxes	111	95	139	177
Minority Interest
Net Income Before Extraordinary Items
Net Income	21	28	139	177
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	18	26	138	176
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	35.9	38.9	60.3	71.9
Dividends per Share
Special Dividends per Share